Truvada for HIV pre-exposure prophylaxis utilization in the United States (2013-2015)

被引：0
|
作者：
Mera, R. [1 ]
McCallister, S. [2 ]
Palmer, B. [3 ]
Mayer, G. [3 ]
Magnuson, D. [4 ]
Rawlings, K. [5 ]
机构：
[1] Gilead Sci, Epidemiol, Foster City, CA USA
[2] Clin Res, Gilead Sci, Foster City, CA USA
[3] Med Sci, Gilead Sci, Foster City, CA USA
[4] Drug Safety Publ Hlth, Gilead Sci, Foster City, CA USA
[5] Med Affairs, Gilead Sci, Foster City, CA USA
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2016年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
TUAX0105LB
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PERCEPTIONS OF HIV PRE-EXPOSURE PROPHYLAXIS IN A HIGH-RISK POPULATION IN URBAN UNITED STATES
    Kwakwa, Helena
    Wahome, Rahab
    Sheller, Alexandra
    [J]. SEXUALLY TRANSMITTED DISEASES, 2014, 41 : S102 - S103
  • [22] Perceptions on HIV Pre-Exposure Prophylaxis Among Urgent Care Clinicians in the Southern United States
    Burns, Charles M.
    Endres, Kyle
    Farrow, Laura
    Mhina, Carl
    Cooper, Alexandra
    Silverberg, Benjamin
    McKellar, Mehri S.
    Okeke, Nwora Lance
    [J]. CURRENT HIV RESEARCH, 2022, 20 (03) : 204 - 212
  • [23] Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review
    Pleuhs, Benedikt
    Quinn, Katherine G.
    Walsh, Jennifer L.
    Petroll, Andrew E.
    John, Steven A.
    [J]. AIDS PATIENT CARE AND STDS, 2020, 34 (03) : 111 - 123
  • [24] Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015
    Smith, Dawn K.
    Van Handel, Michelle
    Grey, Jeremy
    [J]. ANNALS OF EPIDEMIOLOGY, 2018, 28 (12) : 850 - 857
  • [25] Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention
    Patel, Rupa R.
    Mena, Leandro
    Nunn, Amy
    McBride, Timothy
    Harrison, Laura C.
    Oldenburg, Catherine E.
    Liu, Jingxia
    Mayer, Kenneth H.
    Chan, Philip A.
    [J]. PLOS ONE, 2017, 12 (05):
  • [26] The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States
    Siegler, Aaron J.
    Mouhanna, Farah
    Giler, Robertino Mera
    Weiss, Kevin
    Pembleton, Elizabeth
    Guest, Jodie
    Jones, Jeb
    Castel, Amanda
    Yeung, Howa
    Kramer, Michael
    McCallister, Scott
    Sullivan, Patrick S.
    [J]. ANNALS OF EPIDEMIOLOGY, 2018, 28 (12) : 841 - 849
  • [27] The Potential Cost-Effectiveness of Pre-Exposure Prophylaxis Combined with HIV Vaccines in the United States
    Adamson, Blythe J. S.
    Carlson, Josh J.
    Kublin, James G.
    Garrison, Louis P., Jr.
    [J]. VACCINES, 2017, 5 (02):
  • [28] Evaluation of a telemedicine pilot program for the provision of HIV pre-exposure prophylaxis in the Southeastern United States
    Player, Marty S.
    Cooper, Nicole A.
    Perkins, Suzanne
    Diaz, Vanessa A.
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2022, 34 (12): : 1499 - 1505
  • [29] Pre-Exposure Prophylaxis for HIV Upfront
    de Mendoza, Carmen
    [J]. AIDS REVIEWS, 2011, 13 (01) : 57 - 58
  • [30] Pre-Exposure Prophylaxis and HIV Incidence
    Mann, Samuel
    [J]. B E JOURNAL OF ECONOMIC ANALYSIS & POLICY, 2023, 23 (04): : 1163 - 1173
12345